Status:
UNKNOWN
The Canadian Cohort Obstructive Lung Disease
Lead Sponsor:
McGill University Health Centre/Research Institute of the McGill University Health Centre
Collaborating Sponsors:
Canadian Institutes of Health Research (CIHR)
GlaxoSmithKline
Conditions:
COPD
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
40+ years
Brief Summary
Abstract Chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death in Canada. COPD is not just a disease of men, nor is it solely a disease in old age. Women have been underrep...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- All the subjects have taken part in the COLD study, a true population based prevalence study. Subjects must have an inclusion criteria of 40 years and older to participate in the COLD study.
Exclusion
Key Trial Info
Start Date :
January 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2022
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT00920348
Start Date
January 1 2010
End Date
December 1 2022
Last Update
August 27 2018
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Health Sciences Centre
Calgary, Alberta, Canada, T2N 4N1
2
St-Paul's Hospital
Vancouver, British Columbia, Canada, V6Z 1Y6
3
Halifax Infirmary
Halifax, Nova Scotia, Canada, B3H 3A7
4
Kingston General Hospital
Kingston, Ontario, Canada, K7L 2V6